Cognitive Rehabilitation in People With Metabolic Syndrome and Mild Cognitive Deficits

June 28, 2025 updated by: Myrto Koutsonida, University of Ioannina

The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months.

Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ioánnina, Greece, 45110
        • Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 years or older
  • Presence of metabolic syndrome according to the criteria of IDF (2005) or revised NCEP-ATP III (2005)
  • Presence of mild cognitive deficit (-1.5 SD below age and education-adjusted normative mean) in previously administered neuropsychological tests of Trail Making test (Part A & B), Verbal Fluency test (animals and letter "x"), Logical Memory test (immediate and delayed recall)
  • Written informed consent to participate

Exclusion Criteria:

  • Presence of any serious neurological or psychiatric condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computerized cognitive program
25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia, and perform the computerized cognitive training program (BrainHQ) for 45 minutes per session, twice per week, over the 3-month intervention period.
BrainHQ was developed by Posit Science and includes computer-based brain-training exercises organized into six categories: Attention, Brain Speed, Memory, People Skills, Intelligence, and Navigation. Participants were instructed to perform a total of 24 sessions of computerized cognitive training at home, consisting of 45 minutes of training, twice per week, over a 3-month period.
No Intervention: Control group
25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in scores of the Montreal Cognitive Assessment (MoCA) test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
MoCA is a screening test for mild cognitive dysfunction; range 0-30, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Complex Figure tests
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Complex Figures assess visuo-constructional ability and visual memory; range 0-36, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Hopkins Verbal Learning Test-Revised (HVLT-R)
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
HVLT-R assesses verbal memory using a list of words; range 0-36 (immediate recall) and range 0-12 (delayed recall), higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Digit Span test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Digit Span assesses working memory; range 0-14 (performance) and range 2-9 (span) for forward and backward condition, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of semantic Verbal Fluency test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Verbal Fluency assesses executive function that also relies on language component; higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Flanker task
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Flanker task assesses executive function and inhibition; range 0-48, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Continuous Performance Test (CPT)
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
CPT assesses executive function and inhibition; range 0-100, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of Set Shifting
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
Set Shifting assesses executive function and set-shifting; range 0-104, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)
Change in scores of N-back
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
N-back assesses working memory; range 0-30, higher scores represent better cognitive function
baseline, post-intervention (3 months), follow-up (1 year from baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in scores of Everyday Cognition-II (Ecog-II)
Time Frame: baseline, follow-up (1 year from baseline)
Ecog-II is a measure of everyday functioning that includes 41 items to assess memory, language, visual, spatial and perceptual abilities, planning, organization, and divided attention; higher scores represent worse everyday functioning
baseline, follow-up (1 year from baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

March 20, 2025

Study Completion (Actual)

March 20, 2025

Study Registration Dates

First Submitted

December 8, 2022

First Submitted That Met QC Criteria

December 16, 2022

First Posted (Actual)

December 20, 2022

Study Record Updates

Last Update Posted (Actual)

July 2, 2025

Last Update Submitted That Met QC Criteria

June 28, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on Computerized cognitive program

Subscribe